How to discover drug targets in genomics databases
It is the ability to search data - rather than access to data per se - that will determine which companies succeed in the post-genomics era.
Dr Mark Swindells, Inpharmatica Ltd (June 2000)
Keywords: biopharm, bioreactor, genetic engineering, microbial, cell culture, cell separation, genetics, genomics, biosensors, molecular biology, microbiological testing, microbiology, protein engineering, oligonucleotides, collaboration, biotech research, company news, events, biomedical, industry, government, life sciences, education,
investor, publications, medicine, medical, genes, genetic, engineering, recombinant, cell
therapy, microbiology, pharmacology, sequencing, bioengineering, chromosome, genetics, protein, CAT, galactosidase, NPT, immunofluorescense, antibody, chromatography, filtration, nucleotide, m13, lambda, instaprep, perfectprep, bigprep, PerfectRNA, subventions, Inpharmatica Ltd, post-genomics